Turn Therapeutics TTRX
NASDAQ TTRX
$10.03 -0.12 (-1.18%)
As of: Oct 22, 2026 · 3:14 PM EDT

Turn Therapeutics (TTRX) Ending Cash Balance (2024 - 2026)

Updated

Analysis

Turn Therapeutics (TTRX) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,169.89 Bn 1,138.48 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 648.35 Bn 568.21 Bn 17.30 Bn 16.91 Bn
3 AbbVie 504.24 Bn 477.35 Bn 12.70 Bn 6.57 Bn
4 Merck 365.96 Bn 320.33 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 303.28 Bn 267.27 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 4.88 Bn
7 Amgen 242.76 Bn 198.16 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.99 Bn 119.64 Bn 10.94 Bn 1.03 Bn
10 Turn Therapeutics 298.77 Mn 271.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 11.22 Mn
Dec 31, 2025 5.08 Mn
Sep 30, 2025 3.11 Mn
Mar 31, 2025 1.57 Mn
Dec 31, 2024 872,599.00
Sep 30, 2024 788,780.00
API Access

Turn Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TTRX&period=max&api_key=YOUR_API_KEY